Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC or ALA as Adjuvant Therapies in Beta Thalassemia
NCT07157722Phase 3Not yet recruiting
- Sponsor
- Tanta University
- Start
- Aug 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine, alpha-lipoic acid in beta thalassemia, sponsored by Tanta University. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
acetylcysteinealpha-lipoic acid
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on NCT07157722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07157722.